Thomas Roth

Q: What Schools Are Affiliated With Thomas Roth

Thomas Roth is affiliated with the following schools: Université Laval, University of Cincinnati, University of California, Berkeley, Wayne State University, Stanford University

Thomas Roth's AcademicInfluence.com Rankings

Thomas Roth

Engineering

#1401

World Rank

#2072

Historical Rank

Electrical Engineering

#185

World Rank

#214

Historical Rank

engineering Degrees

Thomas Roth

Computer Science

#2356

World Rank

#2459

Historical Rank

Computational Linguistics

#29

World Rank

#29

Historical Rank

Machine Learning

#139

World Rank

#140

Historical Rank

Artificial Intelligence

#248

World Rank

#253

Historical Rank

computer-science Degrees

Download Badge

Engineering
Computer Science

Thomas Roth's Degrees

PhD Computer Science Stanford University
Masters Electrical Engineering University of California, Berkeley
Bachelors Computer Engineering University of California, Berkeley

Similar Degrees You Can Earn

Best Online PhD of Computer Science (Doctorates) 2025

Why Is Thomas Roth Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Thomas Roth's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Principles and Practice of Sleep Medicine (1989) (4207)
Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young Adults (1996) (1727)
Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. (1986) (1586)
Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. (1988) (1575)
Surgical Correction of Anatomic Abnormalities in Obstructive Sleep Apnea Syndrome: Uvulopalatopharyngoplasty (1981) (1154)
Insomnia: definition, prevalence, etiology, and consequences. (2007) (1072)
Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. (1999) (898)
Place of chronic insomnia in the course of depressive and anxiety disorders. (2003) (802)
Shift work sleep disorder: prevalence and consequences beyond that of symptomatic day workers. (2004) (775)
Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. (2002) (674)
The association of insomnia with anxiety disorders and depression: exploration of the direction of risk. (2006) (647)
Epidemiology of DSM-IV Insomnia in Adolescence: Lifetime Prevalence, Chronicity, and an Emergent Gender Difference (2006) (506)
The pediatric daytime sleepiness scale (PDSS): sleep habits and school outcomes in middle-school children. (2003) (505)
Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II. (1999) (433)
Sleep loss and REM sleep loss are hyperalgesic. (2006) (428)
Eszopiclone Co-Administered With Fluoxetine in Patients With Insomnia Coexisting With Major Depressive Disorder (2006) (424)
Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. (2003) (423)
Insomnia and the performance of US workers: results from the America insomnia survey. (2011) (417)
Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. (2010) (417)
Prevalence and Perceived Health Associated with Insomnia Based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep Disorders, Second Edition Criteria: Results from the A (2011) (371)
Sleep-wake disorders based on a polysomnographic diagnosis. A national cooperative study. (1982) (366)
Modafinil for excessive sleepiness associated with shift-work sleep disorder. (2005) (358)
Vulnerability to stress-related sleep disturbance and hyperarousal. (2004) (353)
Caffeine: sleep and daytime sleepiness. (2008) (345)
Sleep Problems, Comorbid Mental Disorders, and Role Functioning in the National Comorbidity Survey Replication (2006) (339)
Insomnia: epidemiology, characteristics, and consequences. (2003) (323)
Sleep fragmentation and daytime sleepiness. (1984) (311)
Early CPAP use identifies subsequent adherence to CPAP therapy. (2007) (304)
Sleep and psychiatric disorders (2000) (298)
Sleep, sleepiness, sleep disorders and alcohol use and abuse. (2001) (292)
Sleep, Sleepiness, and Alcohol Use (2001) (292)
Insomnia causes, consequences, and therapeutics: An overview (2003) (287)
Daytime alertness in patients with chronic insomnia compared with asymptomatic control subjects. (1988) (284)
What are the contributing factors for insomnia in the general population? (2001) (277)
Orexin receptor antagonism for treatment of insomnia (2012) (266)
Clinical diagnoses in 216 insomnia patients using the International Classification of Sleep Disorders (ICSD), DSM-IV and ICD-10 categories: a report from the APA/NIMH DSM-IV Field Trial. (1994) (262)
Sleep, arousals, and oxygen desaturation in chronic obstructive pulmonary disease. The effect of oxygen therapy. (1982) (261)
Neurophysiology of Sleep and Wakefulness: Basic Science and Clinical Implications (2008) (259)
Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia. (2006) (254)
Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial (2014) (239)
A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia. (1994) (235)
Epidemiology of alcohol and medication as aids to sleep in early adulthood. (1998) (229)
Predictors of objective level of daytime sleepiness in patients with sleep-related breathing disorders. (1989) (227)
Stress and sleep reactivity: a prospective investigation of the stress-diathesis model of insomnia. (2014) (226)
Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. (2007) (216)
Sleep in lifetime posttraumatic stress disorder: a community-based polysomnographic study. (2004) (213)
Caffeine effects on sleep taken 0, 3, or 6 hours before going to bed. (2013) (209)
Standard operation procedures for conducting the on-the-road driving test, and measurement of the standard deviation of lateral position (SDLP) (2011) (205)
An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia. (2005) (203)
Pharmacologic Management of Insomnia in Children and Adolescents: Consensus Statement (2006) (201)
Prevalence and polysomnographic correlates of insomnia comorbid with medical disorders. (2011) (198)
Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials (2009) (198)
Effect of Esomeprazole on Nighttime Heartburn and Sleep Quality in Patients with GERD: A Randomized, Placebo-Controlled Trial (2005) (198)
Sleep and pain: interaction of two vital functions. (2005) (191)
Insomnia: pathophysiology and implications for treatment. (2007) (189)
Effects of rapid versus slow accumulation of eight hours of sleep loss. (2001) (187)
Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. (2008) (184)
Night-to-night consistency of apneas during sleep. (1984) (181)
Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials (2016) (180)
Daytime sleepiness: an epidemiological study of young adults. (1997) (178)
Sleep during titration predicts continuous positive airway pressure compliance. (2003) (178)
Recovery of alertness after CPAP in apnea. (1989) (177)
The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy* (2006) (175)
Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment. (2005) (175)
Tolerance to Daytime Sedative Effects of H1 Antihistamines (2002) (174)
The association between obesity and short sleep duration: a population-based study. (2005) (174)
Daytime Sleepiness and Alertness (2011) (168)
A new questionnaire to detect sleep disorders. (2002) (167)
CONSEQUENCES OF SHIFTWORKING ON SLEEP DURATION, SLEEPINESS, AND SLEEP ATTACKS (2010) (165)
Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia. (2007) (165)
Etiologies and sequelae of excessive daytime sleepiness. (1996) (164)
Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia. (2007) (158)
Disrupted nighttime sleep in narcolepsy. (2013) (157)
Multiple naps and the evaluation of daytime sleepiness in patients with upper airway sleep apnea. (1980) (157)
Sleepiness and ethanol effects on simulated driving. (1994) (156)
Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia. (2010) (155)
Evaluation of the effectiveness of uvulopalatopharyngoplasty (1985) (154)
Adverse effects of tracheostomy for sleep apnea. (1981) (154)
Ethanol as a Hypnotic in Insomniacs: Self Administration and Effects on Sleep and Mood (1999) (153)
Nighttime insomnia symptoms and perceived health in the America Insomnia Survey (AIS). (2011) (151)
Hyperarousal and sleep reactivity in insomnia: current insights (2018) (146)
Sedative effects of antihistamines. (1987) (146)
Sleep hygiene practices in a population-based sample of insomniacs. (2005) (145)
Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia (2004) (143)
Daytime sleepiness in young adults. (1988) (141)
Sleep disorders in patients on continuous ambulatory peritoneal dialysis. (1995) (140)
Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. (2008) (139)
Experimental sleep fragmentation. (1994) (138)
Periodic limb movements during sleep: population prevalence, clinical correlates, and racial differences. (2008) (137)
Disturbed Sleep in Patients Complaining of Chronic Pain (1982) (136)
Eight weeks of non-nightly use of zolpidem for primary insomnia. (2000) (135)
Diagnostic concordance for DSM-IV sleep disorders: a report from the APA/NIMH DSM-IV field trial. (1994) (135)
Special report from a symposium held by the World Health Organization and the World Federation of Sleep Research Societies: an overview of insomnias and related disorders--recognition, epidemiology, and rational management. (1996) (134)
Long-term study of the sleep of insomnia patients with sleep state misperception and other insomnia patients. (1992) (133)
The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium. (2004) (130)
Uvulopalatopharyngoplasty. One-year followup. (1985) (128)
Experimental sleep fragmentation in normal subjects. (1987) (126)
Biological Markers for Depression in Chronic Pain (1982) (126)
Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults. (2006) (125)
Level of sleepiness and total sleep time following various time in bed conditions. (1993) (123)
Fragmenting sleep diminishes its recuperative value. (1987) (122)
History of the development of sleep medicine in the United States. (2005) (121)
Sleep reactivity and insomnia: genetic and environmental influences. (2011) (120)
A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia (2007) (119)
Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia. (2011) (119)
Sleep disturbance in psychiatric disorders: effects on function and quality of life in mood disorders, alcoholism, and schizophrenia. (2008) (118)
Evolution of insomnia: current status and future direction. (2004) (118)
Prevalence, associated risks, and treatment patterns of insomnia. (2005) (116)
Eszopiclone in Patients With Insomnia During Perimenopause and Early Postmenopause: A Randomized Controlled Trial (2006) (115)
The prevalence of multiple sleep-onset REM periods in a population-based sample. (2006) (115)
Zolpidem for insomnia (2012) (114)
The 10-year risk of verified motor vehicle crashes in relation to physiologic sleepiness. (2010) (114)
The sleep-wake activity inventory: A self-report measure of daytime sleepiness (1993) (113)
Sleep disturbance and psychiatric disorders (1995) (113)
Pain sensitivity and recovery from mild chronic sleep loss. (2012) (109)
The associations of insomnia with costly workplace accidents and errors: results from the America Insomnia Survey. (2012) (108)
Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia. (2006) (107)
Characteristics of individuals who do or do not seek treatment for chronic insomnia. (1989) (107)
A two-week sleep extension in sleepy normals. (1996) (107)
Zolpidem in the treatment of transient insomnia: a double-blind, randomized comparison with placebo. (1995) (106)
Effects of caffeine on alertness (2005) (105)
Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study. (2008) (102)
Sleep extension in sleepy and alert normals. (1989) (101)
Test-retest reliability of the MSLT. (1988) (100)
Nonrestorative sleep as a distinct component of insomnia. (2010) (98)
The alerting effects of naps in sleep-deprived subjects. (1986) (98)
Moderators and mediators of the relationship between stress and insomnia: stressor chronicity, cognitive intrusion, and coping. (2014) (96)
The frequency of multiple sleep onset REM periods among subjects with no excessive daytime sleepiness. (1996) (95)
Circadian Phase, Sleepiness, and Light Exposure Assessment in Night Workers With and Without Shift Work Disorder (2012) (95)
Sleepiness and motor vehicle accidents. (1988) (94)
Sleep, Sleep Disorders, and Mild Traumatic Brain Injury. What We Know and What We Need to Know: Findings from a National Working Group (2016) (92)
Age‐related Sleep—Wake Disorders at a Sleep Disorder Center (1983) (92)
Neuropsychological function in obstructive sleep apnea syndrome (OSAS) compared to chronic obstructive pulmonary disease (COPD). (1995) (92)
Ethanol and sleep loss: a "dose" comparison of impairing effects. (2003) (91)
Issues in the use of benzodiazepine therapy. (1992) (90)
An epidemiologic study of sleep-disordered breathing symptoms among adolescents. (2006) (89)
Daytime sleepiness and daytime wakefulness: the effect of instruction. (1982) (88)
Comorbid insomnia: current directions and future challenges. (2009) (88)
Treatment of a 12-hour shift of sleep schedule with benzodiazepines. (1984) (88)
Insomnia Pharmacotherapy (2012) (88)
Insomnia, comorbidity, and risk of injury among insured Americans: results from the America Insomnia Survey. (2012) (88)
Ethanol and caffeine effects on daytime sleepiness/alertness. (1987) (87)
Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists. (2003) (87)
Effects of antipsychotic medications on sleep in schizophrenia (2008) (86)
Multiple Sleep Latency Test: Technical Aspects and Normal Values (1992) (86)
A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia. (2010) (86)
Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea (2007) (85)
A seven day actigraphy-based study of rumination and sleep disturbance among young adults with depressive symptoms. (2014) (85)
Stress-related sleep disturbance and polysomnographic response to caffeine. (2006) (85)
Validation of the Restless Legs Syndrome Quality of Life Instrument (RLS-QLI): Findings of a Consortium of National Experts and the RLS Foundation (2004) (84)
Excessive daytime sleepiness associated with insufficient sleep. (1983) (84)
Daytime sleepiness and antihistamines. (1984) (84)
Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression. (2007) (83)
The interplay between daily affect and sleep: a 2‐week study of young women (2014) (83)
Nocturnal and next‐day effects of ethanol and basal level of sleepiness (1991) (82)
Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study (2012) (82)
Clinical factors contributing to the differential diagnosis of primary insomnia and insomnia related to mental disorders. (1997) (81)
Heart rate changes in chronic insomnia (1994) (80)
The Dose Effects of Zolpidem on the Sleep of Healthy Normals (1989) (80)
Rebound insomnia: its determinants and significance. (1990) (79)
Minimal rebound insomnia after treatment with 10-mg zolpidem. (1997) (79)
Gender differences in pharmacokinetics and pharmacodynamics of zolpidem following sublingual administration (2014) (79)
Armodafinil for Treatment of Excessive Sleepiness Associated With Shift Work Disorder: A Randomized Controlled Study (2009) (75)
Hypnotic use for insomnia management in chronic obstructive pulmonary disease. (2009) (75)
Alerting effects of caffeine after normal and restricted sleep. (1991) (75)
Vulnerability to insomnia: the role of familial aggregation. (2008) (74)
Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia. (2012) (74)
Tiagabine is associated with sustained attention during sleep restriction: evidence for the value of slow-wave sleep enhancement? (2006) (74)
Efficacy of digital CBT for insomnia to reduce depression across demographic groups: a randomized trial (2018) (74)
Sleep-wake complaints in patients with sleep-related respiratory disturbances. (1985) (73)
Protriptyline in the treatment of sleep apnoea. (1982) (73)
Tiagabine enhances slow wave sleep and sleep maintenance in primary insomnia. (2006) (73)
The nature of stable insomnia phenotypes. (2015) (72)
MSLT in primary insomnia: stability and relation to nocturnal sleep. (2011) (72)
Effects of alcohol hangover on simulated highway driving performance (2014) (72)
The behavioral morbidity of obstructive sleep apnea. (1999) (72)
Review of the histamine system and the clinical effects of H1 antagonists: basis for a new model for understanding the effects of insomnia medications. (2013) (71)
Efficacy of eight months of nightly zolpidem: a prospective placebo-controlled study. (2012) (71)
Sedative, memory, and performance effects of hypnotics (1994) (70)
Zolpidem Extended-Release Improves Sleep and Next-Day Symptoms in Comorbid Insomnia and Generalized Anxiety Disorder (2009) (70)
Efficacy and Tolerability of 14-Day Administration of Zaleplon 5mg and 10mg for the Treatment of Primary Insomnia (1998) (70)
Evaluation and diagnosis of persistent insomnia. (1981) (69)
Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial. (2011) (69)
Sleepiness and the reinforcing and subjective effects of methylphenidate. (1999) (68)
CONSENSUS FOR THE PHARMACOLOGICAL MANAGEMENT OF INSOMNIA IN THE NEW MILLENNIUM (2001) (67)
Continuous positive airway pressure in severe obstructive sleep apnea reduces pain sensitivity. (2011) (67)
New developments for treating sleep disorders. (2001) (66)
An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults. (2005) (66)
Substance use for insomnia in Metropolitan Detroit. (2002) (66)
Effect of tiagabine on sleep in elderly subjects with primary insomnia: a randomized, double-blind, placebo-controlled study. (2006) (66)
Increased daytime sleepiness enhances ethanol's sedative effects. (1988) (66)
Effects of an experimentally induced rhinovirus cold on sleep, performance, and daytime alertness (2000) (66)
Sleep loss, circadian mismatch, and abnormalities in reorienting of attention in night workers with shift work disorder. (2014) (65)
Comparative effects of pravastatin and lovastatin on nighttime sleep and daytime performance (1992) (65)
Effects of sleep deprivation on daytime sleepiness in primary insomnia. (2000) (65)
Reliability and validity of the brief insomnia questionnaire in the America insomnia survey. (2010) (64)
A randomized, double-blind, placebo-controlled, crossover study of XP13512/GSK1838262 in the treatment of patients with primary restless legs syndrome. (2009) (64)
Efficacy and safety of zolpidem extended release in elderly primary insomnia patients. (2008) (63)
Shift work sleep disorder: burden of illness and approaches to management. (2006) (63)
The effects of ramelteon on respiration during sleep in subjects with moderate to severe chronic obstructive pulmonary disease (2009) (62)
Evaluation of the safety of modafinil for treatment of excessive sleepiness. (2007) (62)
Narcolepsy and Disturbed Nocturnal Sleep (1983) (62)
Intermediate Use of Triazolam: A Sleep Laboratory Study (1976) (62)
Hypnotic residual effects of benzodiazepines with repeated administration. (1986) (62)
Future directions in the management of insomnia. (2001) (60)
Nocturnal sleep, daytime sleepiness and fatigue in fibromyalgia patients compared to rheumatoid arthritis patients and healthy controls: a preliminary study. (2013) (60)
Sex differences in the polysomnographic sleep of young adults: a community-based study. (2006) (60)
Predicting psychopharmacological drug effects on actual driving performance (SDLP) from psychometric tests measuring driving-related skills (2011) (59)
Sleep extension, enhanced alertness and the sedating effects of ethanol (1989) (58)
Pain sensitivity in sleepy pain-free normals. (2009) (58)
Sustained performance with short evening and morning sleeps. (1985) (58)
Caffeine Reversal of Ethanol Effects on the Multiple Sleep Latency Test, Memory, and Psychomotor Performance (2003) (57)
Treating insomnia improves depression, maladaptive thinking, and hyperarousal in postmenopausal women: comparing cognitive-behavioral therapy for insomnia (CBTI), sleep restriction therapy, and sleep hygiene education. (2019) (57)
Effects of ramelteon on insomnia symptoms induced by rapid, eastward travel. (2010) (57)
'Hypnotic' prescription patterns in a large managed-care population. (2004) (56)
Periodic movements during sleep, sleep fragmentation, and sleep-wake complaints. (1984) (56)
Shift Work Sleep Disorder (2012) (55)
Pharmacological effects of sedative-hypnotics, narcotic analgesics, and alcohol during sleep. (1985) (54)
The effects of flurazepam, lorazepam, and triazolam on sleep and memory (1980) (54)
Sleep Disturbance in Substance Use Disorders. (2015) (54)
Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study. (2009) (54)
SLEEP AFTER TRANSMERIDIAN FLIGHTS (1986) (53)
Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakenings. (2008) (53)
A randomized controlled trial of digital cognitive behavioral therapy for insomnia in pregnant women. (2020) (53)
Dose-response effects of tiagabine on the sleep of older adults. (2005) (52)
The alerting effects of short and long naps in narcoleptic, sleep deprived, and alert individuals. (1997) (52)
Effects of hypnotics on memory. (1983) (52)
Effect of pregabalin on sleep in patients with fibromyalgia and sleep maintenance disturbance: A randomized, placebo‐controlled, 2‐way crossover polysomnography study (2012) (52)
Alerting effects of naps in patients with narcolepsy. (1986) (52)
A phase 3, double-blind, randomized, placebo-controlled study of armodafinil for excessive sleepiness associated with jet lag disorder. (2010) (52)
Sleepiness/alertness among healthy evening and morning type individuals. (2001) (51)
The nature of insomnia: a descriptive summary of a sleep clinic population. (1976) (51)
Drivers can poorly predict their own driving impairment: a comparison between measurements of subjective and objective driving quality (2011) (50)
Psychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit/hyperactivity disorder. (2011) (50)
Risk-taking behavior: effects of ethanol, caffeine, and basal sleepiness. (2004) (50)
Tiagabine increases slow-wave sleep in a dose-dependent fashion without affecting traditional efficacy measures in adults with primary insomnia. (2006) (50)
Sedative effects and plasma concentrations following single doses of triazolam, diphenhydramine, ethanol and placebo. (1993) (49)
Sedating effects of ethanol and time of drinking. (1992) (48)
The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials (2010) (48)
Shift work sleep disorder is associated with an attenuated brain response of sensory memory and an increased brain response to novelty: an ERP study. (2010) (48)
Alerting effects of methylphenidate under basal and sleep-deprived conditions. (1997) (48)
The effect of eszopiclone in patients with insomnia and coexisting rheumatoid arthritis: a pilot study. (2009) (47)
Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea (2007) (47)
Psychometric evaluation of daytime sleepiness and nocturnal sleep onset scales in a representative community sample (1999) (47)
Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials. (2016) (46)
Appropriate therapeutic selection for patients with shift work disorder. (2012) (46)
Efficacy of a reduced triazolam dose in elderly insomniacs (1985) (46)
Sleep and cognitive (memory) function: research and clinical perspectives. (2001) (46)
Suvorexant in Elderly Patients with Insomnia: Pooled Analyses of Data from Phase III Randomized Controlled Clinical Trials. (2017) (45)
The effects of ramelteon in a first-night model of transient insomnia. (2009) (45)
A review of the safety profiles of benzodiazepine hypnotics. (1991) (45)
Benzodiazepines and memory. (1984) (45)
The effects of REM sleep deprivation on the level of sleepiness/alertness. (1998) (45)
Effects of uvulopalatopharyngoplasty on the daytime sleepiness associated with sleep apnea syndrome. (1983) (45)
The reliability of the diagnostic features in patients with narcolepsy (1996) (45)
Pharmacology and Hypnotic Efficacy of Triazolam (1983) (44)
Characteristics and determinants of normal sleep. (2004) (44)
Differential sleep, sleepiness, and neurophysiology in the insomnia phenotypes of shift work disorder. (2015) (44)
Gender Differences in Highway Driving Performance After Administration of Sleep Medication: A Review of the Literature (2012) (44)
A review of the effects of pregabalin on sleep disturbance across multiple clinical conditions. (2014) (44)
Predisposition in the Evolution of Insomnia: Evidence, Potential Mechanisms, and Future Directions (2006) (44)
APD125, a selective serotonin 5-HT(2A) receptor inverse agonist, significantly improves sleep maintenance in primary insomnia. (2008) (44)
Daytime sleepiness as a criterion in hypnotic medication trials: comparison of triazolam and flurazepam. (1983) (44)
Sleep organization and regulation. (2000) (44)
The effects of doxepin HCl on sleep and depression. (1982) (43)
Patterns of sleepiness in various disorders of excessive daytime somnolence. (1982) (43)
Effects of diagnosis on treatment recommendations in chronic insomnia--a report from the APA/NIMH DSM-IV field trial. (1997) (42)
Does Effective Management of Sleep Disorders Reduce Substance Dependence? (2012) (41)
Time to response with sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy. (2015) (41)
Validation of the Japanese version of the Ford Insomnia Response to Stress Test and the association of sleep reactivity with trait anxiety and insomnia. (2014) (41)
Triazolam: a sleep laboratory study of a new benzodiazepine hypnotic. (1974) (41)
Drug-related Sleep Stage Changes: Functional Significance and Clinical Relevance. (2010) (41)
Principles and Practice of Sleep Medicine: Fifth Edition (2010) (40)
Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study. (2013) (40)
Twelve months of nightly zolpidem does not lead to dose escalation: a prospective placebo-controlled study. (2011) (40)
Narcolepsy and automatic behavior: a case report. (1979) (39)
Assessing sleep architecture and continuity measures through the analysis of heart rate and wrist movement recordings in healthy subjects: comparison with results based on polysomnography. (2016) (39)
Development and evaluation of a measure to assess restorative sleep. (2014) (39)
The Effect of Insomnia on Tinnitus (2014) (39)
Comparative levels of excessive daytime sleepiness in common medical disorders. (2010) (39)
Sleep evaluation in chronic insomniacs during 14-day use of flurazepam and midazolam. (1990) (38)
Dose-related effects of phenobarbitone on human sleep-waking patterns. (1981) (38)
Effects of sleep loss on waking actigraphy. (2000) (38)
Insomnia as a path to alcoholism: tolerance development and dose escalation (2018) (38)
Electrophysiological assessment (The Multiple Sleep Latency Test) of the biphasic effects of ethanol in humans. (1998) (38)
Impact of stimulant pharmacotherapy on sleep quality: post hoc analyses of 2 large, double-blind, randomized, placebo-controlled trials. (2011) (38)
Comparative efficacy of zolpidem and temazepam in transient insomnia (2001) (38)
Dose determinants of rebound insomnia. (1986) (37)
Effect of Ramelteon, a selective MT1/MT2-receptor agonist, on respiration during sleep in mild to moderate COPD (2008) (37)
Effects of temazepam, flurazepam and quinalbarbitone on sleep: psychomotor and cognitive function. (1979) (37)
Impact of paroxetine on sleep problems in 426 cancer patients receiving chemotherapy: a trial from the University of Rochester Cancer Center Community Clinical Oncology Program. (2012) (37)
Sleep-wake abnormalities in narcolepsy. (1986) (37)
Scoring reliability of the multiple sleep latency test in a clinical population. (2000) (37)
Electroencephalographic power spectral density profile of the orexin receptor antagonist suvorexant in patients with primary insomnia and healthy subjects. (2014) (37)
Prevalence and Predictors of Prescription Sleep Aid Use among Individuals with DSM-5 Insomnia: The Role of Hyperarousal. (2016) (36)
Dose effects of temazepam in transient insomnia. (1990) (36)
Effect of sodium oxybate on disrupted nighttime sleep in patients with narcolepsy (2017) (36)
Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorder (2009) (36)
Depression and suicidal ideation in pregnancy: exploring relationships with insomnia, short sleep, and nocturnal rumination. (2019) (36)
Narcolepsy in a pediatric population. (1988) (36)
Guidelines for the Recording and Evaluation of Pharmaco-Sleep Studies in Man: The International Pharmaco-EEG Society (IPEG) (2013) (35)
Sleep Health and Appropriate Use of OTC Sleep Aids in Older Adults—Recommendations of a Gerontological Society of America Workgroup (2015) (35)
Comparison of pharmacokinetic profiles of zolpidem buffered sublingual tablet and zolpidem oral immediate-release tablet: results from a single-center, single-dose, randomized, open-label crossover study in healthy adults. (2013) (35)
A Phase II Dose-Ranging Study Evaluating the Efficacy and Safety of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Primary Insomnia (2016) (35)
Effects of benzodiazepines on sleep and wakefulness. (1981) (35)
Polysomnographic, performance, and personality differences of sleepy and alert normals. (1990) (35)
A double-blind trial of protriptyline in the treatment of sleep apnea syndrome. (1988) (35)
Residual effects of low-dose sublingual zolpidem on highway driving performance the morning after middle-of-the-night use. (2014) (35)
Effects of theophylline on nocturnal sleep and daytime sleepiness/alertness. (1995) (35)
Principles and Practice of Sleep Medicine, 4th Edition (2005) (35)
The Anxiolytic Effects of Cognitive Behavior Therapy for Insomnia: Preliminary Results from a Web-delivered Protocol. (2015) (34)
Residual sedating effects of ethanol. (1994) (34)
Efficacy and safety of doxepin 6 mg in a model of transient insomnia. (2010) (34)
Meta-Analysis of On-the-Road Experimental Studies of Hypnotics: Effects of Time After Intake, Dose, and Half-Life (2014) (33)
Subjective and polysomnographic characteristics of patients diagnosed with narcolepsy. (1990) (33)
Nocturnal cognitive arousal is associated with objective sleep disturbance and indicators of physiologic hyperarousal in good sleepers and individuals with insomnia disorder. (2019) (33)
The relationship between psychiatric diseases and insomnia. (2001) (33)
Zopiclone as positive control in studies examining the residual effects of hypnotic drugs on driving ability. (2011) (33)
Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications (2018) (33)
Using difficulty resuming sleep to define nocturnal awakenings. (2010) (33)
A physiologic basis for the evolution of pharmacotherapy for insomnia. (2007) (33)
Circadian fluctuation of plasma epinephrine in supine humans (1987) (32)
Hypnotic self administration and dose escalation (1996) (31)
Exacerbation of upper-airway sleep apnea by lymphocytic lymphoma. (1980) (31)
The effects of acute sleep restriction and extension on sleep efficiency. (1988) (31)
Slow wave sleep: does it matter? (2009) (30)
Effectiveness of Benzodiazepine Receptor Agonists in the Treatment of Insomnia: An Examination of Response and Remission Rates. (2017) (30)
Habitual short sleep impacts frontal switch mechanism in attention to novelty. (2011) (30)
Nighttime versus daytime hypnotic self-administration (2002) (30)
Comprar Principles and Practice of Sleep Medicine, 5th Edition Expert Consult - Online and Print | William Dement | 9781416066453 | Saunders (2010) (30)
Sleep and society. (2009) (30)
Predicting circadian misalignment with wearable technology: Validation of wrist-worn actigraphy and photometry in night shift workers. (2020) (30)
Zolpidem and Gender: Are Women Really At Risk? (2019) (30)
Postsurgical patient-controlled opioid self-administration is greater in hospitalized abstinent smokers than nonsmokers. (2012) (30)
A comparison of dream content in laboratory dream reports of schizophrenic and depressive patient groups. (1973) (29)
Effect of gaboxadol on patient-reported measures of sleep and waking function in patients with Primary Insomnia: results from two randomized, controlled, 3-month studies. (2010) (29)
A randomized, double-blind, placebo-controlled, multicenter, 28-day, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advance. (2014) (29)
The state of insomnia and emerging trends. (2007) (29)
Insomnia, Short Sleep, And Snoring In Mid-To-Late Pregnancy: Disparities Related To Poverty, Race, And Obesity (2019) (29)
Days-Out-of-Role Associated With Insomnia and Comorbid Conditions in the America Insomnia Survey (2011) (29)
Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: a polysomnographic study. (2009) (28)
Sleep, Benzodiazepines and Performance (1984) (28)
Vigilance decrement during the on-the-road driving tests: the importance of time-on-task in psychopharmacological research. (2013) (28)
Cortical locations of maximal spindle activity: magnetoencephalography (MEG) study (2009) (28)
Correlation between Sleep Disruption on Postoperative Pain (2015) (28)
Change in epworth sleepiness scale after surgical treatment of obstructive sleep apnea (2011) (28)
Sleepiness: its measurement and determinants. (1982) (28)
Prolonged release melatonin for improving sleep in totally blind subjects: a pilot placebo-controlled multicenter trial (2015) (27)
Sleep after Heavy Alcohol Consumption and Physical Activity Levels during Alcohol Hangover (2019) (27)
The stability and variability of dreaming. (1978) (27)
Pharmacological and medical considerations in hypnotic use. (1982) (27)
Total sleep time, alcohol consumption, and the duration and severity of alcohol hangover (2017) (27)
Familial Risk for Insomnia Is Associated With Abnormal Cortisol Response to Stress (2017) (26)
Perceived Immune Status and Sleep: A Survey among Dutch Students (2015) (26)
Measuring treatment efficacy in insomnia. (2004) (26)
Prevalence and perceived health associated with insomnia based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health and Research Diagnostic Criteria/International Classification of Sleep Disorders. (2010) (26)
Relation between ambulatory actigraphy and laboratory polysomnography in insomnia practice and research (2019) (26)
Hypnotics, alcohol, and caffeine: Relation to insomnia. (1997) (26)
International Task Force on Benzodiazepines (2018) (26)
Sleep disorders and insomnia in the elderly (1993) (26)
Do dreams have meaning? An empirical inquiry. (1976) (26)
Disturbed sleep predicts hypnotic self-administration. (2002) (26)
Comparative behavioral effects of several anticholinergic agents in rats (2004) (26)
Snoring, daytime sleepiness, and sickle cell anemia. (1988) (25)
Familial childhood sleep apnea. (1988) (25)
Dose‐Related Effects of Estazolam on Sleep of Patients with Insomnia (1983) (25)
Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate (2008) (25)
A randomized, double-blind, single-dose, placebo-controlled, multicenter, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advance. (2014) (25)
Phase advance in moderately sleepy and alert normals. (1996) (25)
Chapter 4 – Daytime Sleepiness and Alertness (2005) (24)
Recognition and management of excessive sleepiness in the primary care setting. (2009) (24)
Dose effects of temazepam tablets on sleep. (1986) (24)
Auditory awakening thresholds in sleepy and alert individuals. (1996) (24)
Shift work disorder: overview and diagnosis. (2012) (23)
An overview of the report of the national commission on sleep disorders research (1995) (23)
Rebound insomnia and hypnotic self administration (2005) (23)
Insight Into Reduction of Wakefulness by Suvorexant in Patients With Insomnia: Analysis of Wake Bouts (2018) (23)
Reinforcing and subjective effects of methylphenidate: dose and time in bed. (2004) (23)
Alcohol Hangover, Sleep Quality, and Daytime Sleepiness (2017) (23)
Effects of Ethanol, Diphenhydramine, and Triazolam after a Nap (1993) (23)
Response to CPAP and UPPP in apnea. (1990) (23)
Efficacy and tolerability of indiplon in older adults with primary insomnia. (2007) (23)
Efficacy and safety of as-needed, post bedtime dosing with indiplon in insomnia patients with chronic difficulty maintaining sleep. (2007) (23)
Sleep disorders: an overview. (2004) (23)
Dreams and Dementia: A Laboratory Exploration of Dream Recall and Dream Content in Chronic Brain Syndrome Patients (1975) (23)
Differential effect of codeine on thermal nociceptive sensitivity in sleepy versus nonsleepy healthy subjects. (2010) (22)
Rebound insomnia: duration of use and individual differences. (1991) (22)
Increasing presurgery sleep reduces postsurgery pain and analgesic use following joint replacement: a feasibility study. (2017) (22)
Dose‐response effects of zaleplon as compared with triazolam (0·25 mg) and placebo in chronic primary insomnia (2000) (22)
Isolated cataplexy: a familial study. (1988) (22)
Dose‐related effects of triazolam and flurazepam on a circadian rhythm insomnia (1986) (22)
Dual Orexin Receptor Antagonist, Almorexant, in Elderly Patients With Primary Insomnia: A Randomized, Controlled Study (2017) (22)
Lapses of attention as outcome measure of the on-the-road driving test (2013) (21)
Fragmented Sleep, Daytime Somnolence and Age in Narcolepsy (1989) (21)
Behavioral Morbidity of Apnea (1988) (21)
Hypnotic effects of low doses of quazepam in older insomniacs. (1997) (21)
Effects of armodafinil on simulated driving and alertness in shift work disorder. (2014) (21)
Characteristics of Disturbed Sleep in Patients With Fibromyalgia Compared With Insomnia or With Pain-Free Volunteers (2016) (21)
Hypnotics: An update (2003) (21)
Narcolepsy in a 7-year-old child. (1983) (21)
Blood drug concentrations of benzodiazepines correlate poorly with actual driving impairment. (2013) (21)
Assessment of sleep in patients with fibromyalgia: qualitative development of the fibromyalgia sleep diary (2014) (20)
Excursions out‐of‐lane versus standard deviation of lateral position as outcome measure of the on‐the‐road driving test (2014) (20)
Individual differences in the sedating effects of ethanol. (1990) (20)
The sleep/wake habits of patients diagnosed as having obstructive sleep apnea. (1997) (20)
Long-term issues in the treatment of sleep disorders. (2007) (20)
Establishment and implementation of standardized sleep laboratory data collection and scoring procedures. (1978) (20)
Daytime CPAP titration: a viable alternative for patients with severe obstructive sleep apnea. (1998) (20)
Hypnotics and behavior. (1990) (20)
Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study. (2013) (20)
Waking and dreaming mentation: A test of their interrelationship (1981) (20)
Chapter 81 – Pharmacologic Treatment of Insomnia: Benzodiazepine Receptor Agonists (2010) (20)
Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a 2-week randomized outpatient trial. (2015) (20)
Efficacy and tolerability of indiplon in transient insomnia. (2007) (19)
The Efficacy of Triazolam and Chloral Hydrate in Geriatric Insomniacs (1980) (19)
Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a randomized, 6-week sleep laboratory trial. (2015) (19)
Alcohol-Induced Sleepiness and Memory Function (1995) (19)
Effects of central nervous system drugs on driving: speed variability versus standard deviation of lateral position as outcome measure of the on‐the‐road driving test (2014) (19)
Sleep-wake state and memory function. (2000) (19)
Physiological correlates of insomnia. (2014) (19)
Quantitative Measures of Nocturnal Insomnia Symptoms Predict Greater Deficits Across Multiple Daytime Impairment Domains (2015) (18)
Hypnotic self administration: forced-choice versus single-choice (1997) (18)
The differential effects of short- and long-acting benzodiazepines upon nocturnal sleep and daytime performance. (1980) (18)
The Effect of a Single Dose of Quazepam (Sch-16134) on the Sleep of Chronic Insomniacs (1979) (18)
Temazepam's efficacy in patients with sleep onset insomnia. (1984) (18)
Self-reported levels of sleepiness among subjects with insomnia. (2001) (18)
Insomnia in shift work disorder relates to occupational and neurophysiological impairment. (2015) (18)
Commentary: Is Melatonin Administration an Effective Hypnotic? (1997) (17)
The Prescription of Benzodiazepines for Panic Disorder: Time for an Evidence-Based Educational Approach. (2018) (17)
Excessive sleepiness: under-recognized and essential marker for sleep/wake disorder management (2010) (17)
Signs and symptoms associated with cataplexy in narcolepsy patients (1990) (17)
Effect of sodium oxybate, modafinil, and their combination on disrupted nighttime sleep in narcolepsy. (2017) (17)
Effects of zaleplon or triazolam with or without ethanol on human performance. (2001) (17)
Patient-Reported Outcomes in Insomnia: Development of a Conceptual Framework and Endpoint Model (2013) (17)
Effects of excessive daytime sleepiness and fatigue on overall health and cognitive function. (2015) (17)
Determinants of residual effects of hypnotics. (1985) (17)
Public health and insomnia: Consensus statement regarding its status and needs for future actions (1999) (17)
Rebound Insomnia: Duration of Use and Individual (1991) (16)
Hypersomnolence and neurocognitive performance in sleep apnea. (1995) (16)
Chapter 63 – Pharmacologic Treatment of Primary Insomnia (2005) (16)
The Association of Insomnia, Perceived Immune Functioning, and Irritable Bowel Syndrome Complaints (2018) (16)
Relationship of Psychopathology to Insomnia in the Elderly (1982) (16)
Enforced 24-hour recovery following sleep deprivation. (1991) (16)
Management of insomniac patients (1996) (16)
Use of a post-sleep questionnaire-interactive voice response system (PSQ-IVRS) to evaluate the subjective sleep effects of ramelteon in adults with chronic insomnia. (2011) (16)
Amnesic effects of lormetazepam. (1984) (16)
A single‐dose, randomized, double‐blind, double dummy, placebo and positive‐controlled, five‐way cross‐over study to assess the pharmacodynamic effects of lorediplon in a phase advance model of insomnia in healthy Caucasian adult male subjects (2014) (15)
Effects of acute administration of brotizolam in subjects with disturbed sleep. (1983) (15)
Length polymorphism in the Period 3 gene is associated with sleepiness and maladaptive circadian phase in night‐shift workers (2015) (15)
Mortality in obstructive sleep apnea. (1990) (15)
Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy (2021) (15)
Gender Differences in the Efficacy and Safety of Chronic Nightly Zolpidem. (2016) (15)
Reversal by caffeine of triazolam-induced impairment of waking function. (1988) (15)
Towards quantitative cutoffs for insomnia: how current diagnostic criteria mischaracterize remission. (2016) (15)
Effects of estazolam and triazolam on transient insomnia associated with phase‐shifted sleep (1991) (15)
Inclusion and Exclusion Criteria of Clinical Trials for Insomnia (2018) (14)
The dose effects of zopiclone (1989) (14)
Sleep and alertness disturbance and substance use disorders: A bi-directional relation (2021) (14)
Hypnotics and aircrew. (1985) (14)
Recognizing and managing obstructive sleep apnea in primary care. (2009) (14)
The Mood-regulating Function of Sleep (1973) (14)
Personality differences between insomniac and non-insomniac psychiatry outpatients. (1981) (14)
Objective sleep disturbance is associated with poor response to cognitive and behavioral treatments for insomnia in postmenopausal women. (2020) (14)
Repeated nocturnal sleep latencies in narcoleptic, sleepy and alert subjects (1999) (14)
New Trends In Insomnia Management (1999) (14)
Patient identification. (2007) (14)
A novel forehead temperature-regulating device for insomnia: a randomized clinical trial (2017) (14)
The effects of midazolam and temazepam on sleep and performance when administered in the middle of the night. (1985) (13)
Sleep maintenance difficulties in insomnia are associated with increased incidence of hypertension. (2015) (13)
Flurazepam for Short‐Term Treatment of Complaints of Insomnia (1982) (13)
Pharmacological treatment of sleep disorders. (1988) (13)
Daytime Sleep Disturbance in Night Shift Work and the Role of PERIOD3. (2018) (13)
Rebound insomnia in normals and patients with insomnia after abrupt and tapered discontinuation (2005) (13)
Mood change and the physiology of sleep. (1976) (13)
The prevalence and nature of stopped on-the-road driving tests and the relationship with objective performance impairment. (2012) (13)
Narcolepsy: treatment issues. (2007) (13)
Measurement of Sleepiness/Alertness: Multiple Sleep Latency Test (1994) (12)
Assessing Stress-Induced Sleep Reactivity in College Students: The European Portuguese Version of the Ford Insomnia Response to Stress Test (FIRST) (2018) (12)
Polysomnographic and MMPI characteristics of patients with insomnia. (1984) (12)
The Effects of Armodafinil on Objective Sleepiness and Performance in a Shift Work Disorder Sample Unselected for Objective Sleepiness (2014) (12)
Pharmacokinetics of Zolpidem from Sublingual Zolpidem Tartrate Tablets In Healthy Elderly Versus Non-Elderly Subjects (2014) (12)
Defining insomnia: the role of quantitative criteria. (2006) (12)
Sleep Extension Normalizes ERP of Waking Auditory Sensory Gating in Healthy Habitually Short Sleeping Individuals (2013) (12)
Irritable Bowel Syndrome, Immune Fitness, and Insomnia: Results from an Online Survey Among People Reporting Sleep Complaints (2019) (12)
Drugs, sleep disorders, and aging. (1989) (12)
Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 data (2017) (12)
SEDATING EFFECTS OF ETHANOL AFTER A NAP (1989) (12)
Mirtazapine as positive control drug in studies examining the effects of antidepressants on driving ability. (2015) (12)
The perception of sleep as a function of the level of daytime sleepiness among patients with obstructive sleep apnea. (1998) (12)
Pharmacotherapy of Insomnia (2010) (11)
Sleep restriction, ethanol effects and time of day (1996) (11)
Sleep laboratory and performance evaluation of midazolam in insomniacs. (1983) (11)
Biological differences in endogenous depressive placebo responders versus nonresponders: Dexamethasone suppression test and sleep EEG data (1988) (11)
Evaluation of the effectiveness of uvulopalatopharyngoplasty (2015) (11)
A Phase 2 Randomized Dose-Finding Study With Esmirtazapine in Patients With Primary Insomnia (2016) (11)
Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: Two randomized controlled multicentre trials (2009) (11)
Pregabalin Improves Fibromyalgia-related Sleep Disturbance (2016) (11)
Mindfulness and nocturnal rumination are independently associated with symptoms of insomnia and depression during pregnancy. (2020) (11)
Diagnosis and management of insomnia. (2000) (10)
Biperiden administration during REM sleep deprivation diminished the frequency of REM sleep attempts. (1992) (10)
Influence of food on pharmacokinetics of zolpidem from fast dissolving sublingual zolpidem tartrate tablets (2013) (10)
Hyperarousal in insomnia and hypnotic dose escalation. (2016) (10)
Rebound insomnia. (1980) (10)
Treatment regimen and hypnotic self-administration (2001) (10)
How representative are insomnia clinical trials? (2017) (10)
Readaptation to the laboratory in long-term sleep studies (1981) (10)
Methylphenidate Significantly Reduces Lapses of Attention During On-Road Highway Driving in Patients With ADHD (2014) (10)
Hypercapnia and sleep O2 desaturation in chronic obstructive pulmonary disease. (1987) (10)
Chronic hypnotic efficacy of estazolam. (1986) (10)
Sexual function and distress in postmenopausal women with chronic insomnia: exploring the role of stress dysregulation (2019) (9)
Social and economic consequences of sleep disorders (1996) (9)
Introduction--Advances in our understanding of insomnia and its management. (2007) (9)
Efficacy and Safety of Sleep-Promoting Agents (2008) (9)
Behavioral sleep medicine. (2013) (9)
Thirty Years of Dutch Drugs and Driving Research: Strengths and Limitations of the On-The-Road Highway Driving Test and Future Challenges (2012) (9)
One-year Followup (2017) (8)
Effects of temazepam soft gelatin capsules on the sleep of subjects with insomnia (1985) (8)
Mortality in sleep apnea. (1989) (8)
Hyperarousal in insomnia: pre-sleep and diurnal cortisol levels in response to chronic zolpidem treatment. (2019) (8)
Armodafinil in the treatment of sleep/wake disorders (2010) (8)
efficacy and safety of suvorexant, an orexin receptor antagonist, in patients with primary insomnia: a 3-month phase 3 trial (trial #1) : o324 (2012) (8)
Effects of a single dose of flurazepam on the sleep of healthy volunteers. (1984) (8)
HLA DR2 in narcolepsy with sleep-onset REM periods but not cataplexy (1991) (8)
Dose-related effects of flurazepam on human sleep-waking patterns (2004) (8)
Understanding the effects of age on "normal" human sleep. (2004) (8)
Examining Patient Feedback and the Role of Cognitive Arousal in Treatment Non-response to Digital Cognitive-behavioral Therapy for Insomnia during Pregnancy (2021) (8)
Sleep, Alcohol, and Quality of Life (2008) (8)
Safety of Insomnia Pharmacotherapy (2006) (8)
Sleep duration, insomnia and longevity. (2009) (8)
Triazolam: a new benzodiazepine hypnotic and its effect on mood. (1974) (8)
Chapter 87 – Pharmacologic Treatment of Insomnia: Benzodiazepine Receptor Agonists (2017) (8)
Some behavioral effects of Ditran (JB 329) in rats. (1967) (7)
Sleep and Pain in Subjects with Fibromyalgia and Comorbid Insomnia: Double-blind, Crossover, Study of Suvorexant 20 mg versus Placebo. (2020) (7)
Ethanol and daytime sleepiness (1990) (7)
The chronic efficacy of midazolam. (1990) (7)
A dose response study of the hypnotic effectiveness of alprazolam and diazepam in normal subjects (2004) (7)
The detection of brief daytime sleep episodes. (1999) (7)
Eligibility requirements in hypnotic trials. (1985) (7)
Pregabalin improves fibromyalgia related sleep disturbance (2013) (7)
Psychometric profiles of patient populations with excessive daytime sleepiness. (1990) (7)
Middle-of-the-night hypnotic use in a large national health plan. (2013) (7)
Chronic insufficient sleep and its recovery. (2003) (7)
The psychological nature of the 'REM' dream. I. A comparison of the REM dream report and T.A.T. stories (1976) (7)
Mood before and after sleep (1976) (7)
Sleep in Adults With ADHD and the Effects of Stimulants (2009) (7)
Typologies of individuals vulnerable to insomnia: a two-step cluster analysis (2020) (7)
The acute effect of quazepam on the sleep of chronic insomniacs. A dose-response study. (1981) (6)
Chapter 132 – Medication and Substance Abuse (2010) (6)
Shift Work: A Perspective on Shift Work Disorder-Is Prevention the Answer? (2019) (6)
Guidelines for in-home testing: a need for reassessment. (1995) (6)
Middle-of-the-night administration of sleep medication: a critical review of the effects on next morning driving ability. (2014) (6)
Chapter 16 – Measurement of Sleepiness and Alertness: Multiple Sleep Latency Test (2009) (6)
Sleep in the elderly: a clinical challenge (1993) (6)
Over-the-counter sleep aid medications and insomnia (2008) (6)
Arousability and Fall Risk During Forced Awakenings From Nocturnal Sleep Among Healthy Males Following Administration of Zolpidem 10 mg and Doxepin 6 mg: A Randomized, Placebo-Controlled, Four-Way Crossover Trial (2017) (6)
Sleep and memory. (1988) (6)
Characteristics of insomnia in the united states (2018) (5)
Prevalence of nocturnal oxygen desaturation in patients admitted to a geriatric rehabilitation unit (1995) (5)
Novel outcome measures of sleep, sleep loss and insomnia. (2008) (5)
Pharmacology of Benzodiazepine Receptor Agonist Hypnotics (2012) (5)
How well can a large number of polysomnography sleep measures predict subjective sleep quality in insomnia patients? (2019) (5)
Sleepiness and sleep onset REM periods in the absence of clinical symptomatology (1994) (5)
Sleep, benzodiazepines and performance. Experimental methodologies and research prospects. (1984) (5)
Insomnia and driving ability. (2014) (5)
The biphasic effects of ethanol on sleep latency (1994) (5)
Connectivity analysis of novelty process in habitual short sleepers (2012) (5)
Efficacy and safety of esmirtazapine in adult outpatients with chronic primary insomnia: a randomized, double-blind placebo-controlled study, and open-label extension. (2020) (5)
Gender influences on efficacy and safety of sublingual zolpidem tartrate for middle‐of‐the‐night awakening in insomnia (2014) (5)
Epidemiology of medication as aids to alertness in early adulthood. (1999) (5)
Patient-management strategies. (2007) (5)
414. Daytime sleepiness in young adults (1996) (5)
Challenges in the comorbid condition. (2007) (5)
Nocturnal sleep latencies among alert, alert-deprived and sleepy subjects. (1996) (5)
Introduction: Definitions, measurements, and management in insomnia. (2004) (5)
Highway driving safety the day after using sleep medication: the direction of lapses and excursions out‐of‐lane in drowsy drivers (2018) (5)
Identification and Management of Insomnia in Alzheimer's Disease. (2019) (4)
Sleep-wake variations and drug self-administration. (2001) (4)
Management of insomnia--the role of zaleplon. (2002) (4)
A double-blind evaluation of metiapine in hospitalized acute schizophrenics. (1975) (4)
Treatment regimen and subsequent self-administration of benzodiazepine-hypnotics (1994) (4)
What is the nature of nonrestorative sleep? (2010) (4)
Drugs of Abuse and Sleep (2005) (4)
Effects of reduced time in bed on daytime sleepiness and recovery sleep in fibromyalgia and rheumatoid arthritis. (2015) (4)
Alcohol, Alcoholism, and Sleep (2005) (4)
Post Hoc Analysis of Data from Two Clinical Trials Evaluating the Minimal Clinically Important Change in International Restless Legs Syndrome Sum Score in Patients with Restless Legs Syndrome (Willis-Ekbom Disease). (2016) (4)
Effectiveness of benzodiazepine receptor agonists in the treatment of insomnia: An examination of response and remission rates. (2016) (4)
Insomnia and sleep-related disorders (2008) (4)
Sleep, Sleep Disorders, and Mild Traumatic Brain Injury. What We Know and What We Need to Know: Findings from a National Working Group (2016) (4)
Issues in drug-related performance impairment. (1992) (4)
0398 ARE CLINICAL TRIAL PARTICIPANTS REPRESENTATIVE FOR PATIENTS WITH INSOMNIA (2017) (4)
DSM-5 insomnia disorder in pregnancy: associations with depression, suicidal ideation, and cognitive and somatic arousal, and identifying clinical cutoffs for detection (2022) (4)
State-Altering Actions of Ethanol, Caffeine, and Nicotine (1998) (4)
Early onset and accumulation of REM sleep in depression: a study of the phase-advance hypothesis. (1990) (4)
Can the Orexin Antagonist Suvorexant Preserve the Ability to Awaken to Auditory Stimuli While Improving Sleep? (2019) (4)
Restless Legs Syndrome : A Review of Diagnosis and Management (2006) (4)
Armodafinil Improves Subjective Measures of Sleepiness In Patients With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome, Narcolepsy, and Shift Work Sleep Disorder (2006) (4)
An introduction to the clinical correlates of disrupted slow-wave sleep. (2010) (4)
Introduction: New Developments for Treating Sleep Disorders (2001) (4)
The Sleep–Wake Cycle: An Overview (2019) (4)
Benzodiazepine associated reversal of the effects of experimental sleep fragmentation (1993) (4)
Noise Disturbance and Sleep. The Relationship of Noise Disturbed Sleep to Post-Sleep Behavior: An Exploratory Study. (1971) (4)
Chapter 140 – Medication and Substance Abuse (2017) (3)
Chapter 46 – Effects of Hypnotic Drugs on Driving Performance (2017) (3)
0521 Daridorexant (ACT-541468), A Dual Orexin Receptor Antagonist for the Treatment of Insomnia Disorder: Double Blind, Randomized, Phase 3 Studies for Efficacy and Safety in Adult and Elderly Patients (2020) (3)
Characteristics of chronic insomniacs examined in a multicenter 14-day study of flurazepam and midazolam. (1990) (3)
The Nature of Insomnia (2007) (3)
Treating Excessive Daytime Sleepiness in Patients With Narcolepsy. (2020) (3)
Impact of lemborexant treatment on insomnia severity: analyses from a 12-month study of adults with insomnia disorder. (2022) (3)
New perspectives on the pharmacologic management of insomnia. (2001) (3)
Dose-related effects of flurazepam on human sleep-walking patterns. (1981) (3)
NIH funding of sleep research: a prospective and retrospective view. (1999) (3)
0371 Lemborexant Treatment for Insomnia in Phase 3: Impact on Disease Severity (2019) (3)
Protriptyline therapy for upper airway sleep apnea (1982) (3)
The Sustained 6-Month Efficacy of Eszopiclone in the Treatment of Chronic Insomnia (2004) (3)
The timing of sleep opportunities in a seven-night sleep restriction. (2003) (3)
Managing excessive daytime sleepiness. (2015) (3)
Replacement of Benzodiazepines with ‘Old-Fashioned’ Hypnotics (1993) (3)
Comprar Principles And Practice Of Sleep Medicine, Expert Consult Premium Edition - Enhanced Online Features And Print | William C. Dement | 9781437707311 | Saunders (2010) (3)
Academic Highlights: Sleepiness Versus Sleeplessness: Shift Work and Sleep Disorders. [CME] (2004) (3)
Development of the Nocturia Sleep Quality Scale: a patient-reported outcome measure of sleep impact related to nocturia. (2019) (3)
The effect of comorbid psychiatric and medical illnesses on sleep disorder treatment. (2015) (3)
The Evolution of Insomnia in Relation to Comorbidity (2008) (3)
Maintenance of Wakefulness With Lisdexamfetamine Dimesylate, Compared With Placebo and Armodafinil in Healthy Adult Males Undergoing Acute Sleep Loss (2014) (3)
A dose-response study of the hypnotic effectiveness of ketazolam in normal subjects (1981) (3)
Sleep architecture following treatment of patients with middle-of-the-night insomnia with buffered sublingual zolpidem compared to placebo (2013) (3)
Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial (2022) (3)
Dream translation. (1977) (3)
0610 Pharmacokinetics And Dose Proportionality Of FT218, An Investigational Controlled Release Formulation Of Sodium Oxybate For Once Nightly Dosing (2019) (2)
Efficacy of SM‐1 in a transient insomnia model (2019) (2)
0338 Insomnia in Late Pregnancy: Characterizing Phenotypes and Identifying Associated Factors (2019) (2)
Efficacy and tolerability studies evaluating a sleep aid and analgesic combination of naproxen sodium and diphenhydramine in the dental impaction pain model in subjects with induced transient insomnia (2015) (2)
Panel discussion: changing how we think about insomnia. (2004) (2)
Definitions, Measurements, and Management in Insomnia (2004) (2)
Minimal Clinically Important Improvement in IRLS Total Score in Patients with Restless Legs Syndrome: A Post Hoc Analysis from a 6-Month Placebo-Controlled US-Based Study with Rotigotine Transdermal System (P02.059) (2013) (2)
P.1.i.035 Objective and subjective efficacy of ramelteon 4mg in adults with chronic insomnia (2009) (2)
Obituary for Peter Hauri (1933–2013). (2013) (2)
Recognition and assessment of shift work disorder. (2011) (2)
Protriptyline inthetreatment ofsleep apnoea (1982) (2)
0373 Effects of Suvorexant on Sleep in Fibromyalgia (2019) (2)
Sleep-wake complaints and their relation to sleep disturbance. (1988) (2)
The Art of Good Sleep (2004) (2)
Insomnia Complaints and Perceived Immune Fitness in Young Adults with and without Self-Reported Impaired Wound Healing (2022) (2)
0609 Pharmacokinetics And Formulation Selection Of Ft218, An Investigational Controlled-release Sodium Oxybate Formulation Designed For Once Nightly Dosing (2019) (2)
Is a blunted cortisol response to stress a premorbid risk for insomnia? (2022) (2)
Sleep disorders medicine. (1988) (2)
032 THE AMERICA INSOMNIA SURVEY: AN EPIDEMIOLOGICAL STUDY OF INSOMNIA IN SUBJECTS WITH VARIOUS COMORBIDITIES AND/OR CONDITIONS (2009) (2)
Next-morning effects of hypnotic drugs on attention, psychomotor performance, and memory functioning: implications for traffic safety (2016) (2)
sleep-Wake disorders: Can a CMe Panel discussion activity improve Clinical Practice? (2010) (2)
Can the Orexin Antagonist Suvorexant Preserve the Ability to Awaken to Auditory Stimuli While Improving Sleep? (2019) (2)
P.5.e.005 A 12-week study of eszopiclone in elderly out-patients with primary insomnia: effects of treatment discontinuation (2008) (2)
Shift work disorder case studies: applying management principles in clinical practice. (2012) (2)
Reflecting on a year of growth, change, and strong science (1999) (2)
Sleep to Reduce Incident Depression Effectively (STRIDE): study protocol for a randomized controlled trial comparing stepped-care cognitive-behavioral therapy for insomnia versus sleep education control to prevent major depression (2022) (2)
The Role of Pharmacological Interventions for Sleep Deprivation (2004) (2)
Evaluation of eszopiclone and escitalopram oxalate co-therapy in patients with generalized anxiety disorder and insomnia (2007) (2)
Alcohol, sleep, sleep disorders and consequent daytime impairment (2008) (1)
Understanding neuronal pathways: novel targets for the management of insomnia. (2007) (1)
Ford Insomnia Response to Stress Test (2012) (1)
Toward a classification of medications for sleep and circadian rhythm disorders (2013) (1)
Multiple Sleep Latency Test (2017) (1)
0006 The Role of Stress in Sleep in Night Shift Workers: Going Beyond Circadian Misalignment (2020) (1)
Determination of the Minimal Clinically Important Improvement in IRLS Total Score in Patients with Moderate to Severe Restless Legs Syndrome Treated with Rotigotine Transdermal System: A Post Hoc Analysis from a 6-Month Placebo-Controlled European Study (P02.056) (2013) (1)
Conclusion: directions for future research into optimizing outcomes measurement in sleep medicine. (2008) (1)
Normal Sleep Physiology (1996) (1)
Sleep and Sleep Disorders (2012) (1)
INSOMNIA AND PERFORMANCE OF US WORKERS (2011) (1)
Sleep difficulties and use of prescription and non-prescription sleep aids in Portuguese Higher Education students (2021) (1)
EFFECT OF PREGABALIN ON QUANTITATIVE ELECTROENCEPHALOGRAPHY (QEEG) DURING NON-REM SLEEP IN PATIENTS WITH FIBROMYALGIA AND SLEEP MAINTENANCE DIFFICULTIES (2011) (1)
0372 Digital Cognitive Behavioral Therapy for Insomnia Reduces Incident Depression at One-year Follow-up (2018) (1)
0394 Efficacy of Cognitive Behavioral Therapy for Insomnia on Post-Menopausal Quality of Life (2018) (1)
Behavioral and Environmental Countermeasures (2004) (1)
Dose-related effects of triazolam and flurazepam on a circadian rhythm insomnia (1987) (1)
0203 To and From the Night Shift: Risky On-the-Road Driving in Night Shift Workers (2020) (1)
SLEEPINESS AND MOTOR VEHICLE ACCIDENTS. MEDICINES AND ROAD TRAFFIC SAFETY (1988) (1)
489 Pivotal Phase 3 Study of FT218, a Once-Nightly Sodium Oxybate Formulation, in Patients With Narcolepsy: REST-ON Primary Results (2021) (1)
Metiapine in acute schizophrenic patients. (1973) (1)
The challenges of interpreting residual effects of hypnotics. (2011) (1)
Investigating nonrestorative sleep. (2012) (1)
Performance of Somno-Art Software compared to polysomnography interscorer variability: A multi-center study. (2022) (1)
Shift Work Sleep Disorder: Prevalence and Consequences Beyond that of Symptomatic Day Workers (2005) (1)
1086 CBT-I FOR MENOPAUSE RELATED INSOMNIA ALSO REDUCES DEPRESSION SEVERITY (2017) (1)
Measurement of Sleepiness and Alertness (2009) (1)
Pain and sleep (2021) (1)
The association between insomnia and perceived health status (2015) (1)
Sleepiness Versus Sleeplessness: Shift Work and Sleep Disorders in the Primary Care Setting. (2004) (1)
A multicenter study of sleep, performance, and plasma levels in chronic insomniacs during 14-day use of flurazepam and midazolam: executive summary. (1990) (1)
EFFECT OFMIDDLE-OF-THE-NIGHT DOSES OF ZOLPIDEMSUBLINGUAL TABLET 3.5 MG ON NEXT-MORNING DRIVING PERFORMANCE (2011) (1)
S14THE HEALTH AND BEHAVIOURAL CONSEQUENCES OF ALCOHOL HANGOVER (2013) (1)
Pharmacodynamic and pharmacokinetic profile of SM‐1, a triple‐drug combination to increase total sleep time (2019) (1)
Effect of sodium oxybate (SXB), modafinil and combination on disrupted nighttime sleep in narcolepsy (2013) (1)
Conclusion: challenges in the comorbid condition. (2007) (1)
Pre‐pandemic sleep reactivity prospectively predicts distress during the COVID‐19 pandemic: The protective effect of insomnia treatment (2022) (1)
Effects of alcohol hangover on simulated highway driving performance (2014) (1)
P.5.e.004 The efficacy of 12 weeks of eszopiclone treatment in elderly patients with primary insomnia: effect on daytime function (2008) (1)
Pharmacotherapy of Excessive Sleepiness (2012) (1)
PND10 THE AMERICA INSOMNIA SURVEY (AIS): AN EPIDEMIOLOGY STUDY OF INSOMNIA PREVALENCE AND BURDEN IN A REPRESENTATIVE POPULATION (2010) (1)
Management of Insomnia (2012) (1)
CONTROLLED STUDY OF THE EFFICACY OF EIGHT MONTHS OF NIGHTLY ZOLPIDEM (2012) (1)
Introduction: narcolepsy and excessive daytime sleepiness: from the bench to the bedside. (2007) (1)
Description of Insomnia (2013) (1)
[Effects of the chronic administration of triazolam 0.50 mg on the sleep of insomniacs]. (1982) (1)
Sleep Therapy: New Generation Pharmacologic Agents for Managing Insomnia. (2007) (1)
Sleep and health: research and clinical perspectives. (2000) (1)
0359 EFFICACY OF BEHAVIORAL INSOMNIA TREATMENT ON POST-MENOPAUSAL QUALITY OF LIFE (2017) (1)
The Impact of Having a 15-min Break With and Without Consuming an Energy Drink on Prolonged Simulated Highway Driving (2017) (1)
Gender effects on zolpidem efficacy and safety (2015) (1)
The association of sleep quality and insomnia with dietary intake of tryptophan and niacin (2015) (1)
0428 Insomnia And Stress: Associations With Mental Resilience And Mood (2018) (1)
0449 Correlations Between Sleep Parameters and ISI Total Score in Subjects with Moderate to Severe Insomnia Treated with Lemborexant (2022) (0)
0785 CYTOKINES, SLEEP, AND DAYTIME SLEEPINESS (2017) (0)
Irritable bowel syndrome, sleep, and daytime sleepiness (2017) (0)
Overcoming Barriers to the Diagnosis and Treatment of Insomnia. (2020) (0)
0492 Sleep and Hyperarousal: Inability to Discontinue Chronic Hypnotic Use (2020) (0)
336 Effect of Lemborexant Versus Placebo and Zolpidem on REM Sleep by Quarter Night Intervals in Older Adults with Insomnia Disorder (2021) (0)
0494 Ability to Discontinue Chronic Hypnotic Use: An Update (2020) (0)
Changing How We Think About Insomnia Special Issues Board Panel Members (2004) (0)
Nocturnal rumination as a mediator between sleep disturbance and negative affect (2015) (0)
P 055 Neuroticism and life adversity in the development of depressive symptoms (2007) (0)
The Effect of Sleep Disruption on Postoperative Pain (2014) (0)
Objective Sleepiness Following Sleep Restriction in Rheumatoid Arthritis and Fibromyalgia (2007) (0)
Topographic Distribution of Sleep Spindles using 2 DII (2002) (0)
Treatment of middle of the night insomnia: Current therapeutic approaches (2011) (0)
A new questionnaire to detect sleep disorders q (2002) (0)
T-O-128 OBJECTIVE AND SUBJECTIVE BENEFITS OF PREGABALIN ON MEASURES OF SLEEP AND PAIN IN PATIENTSWITH FIBROMYALGIA AND SLEEP MAINTENANCE DISTURBANCE (2011) (0)
Insomnia, Total Sleep Time and the 2D:4D Digit Ratio (2018) (0)
Baseline characteristics of idiopathic hypersomnia subjects enrolled in a clinical trial (ARISE2) (2019) (0)
Managed care considerations. (2007) (0)
Positive beliefs about continuous positive airway pressure (CPAP) treatment are strongly related to compliance behaviour (2001) (0)
Conclusion: Challenges in insomnia treatment (2006) (0)
Narcolepsy: validation of a daily electronic diary (2017) (0)
Increasing preoperative sleep reduces postoperative pain and analgesic use (2014) (0)
Patients disrupted Nighttime sleep in Narcolepsy (0)
A multicenter, double-blind, placebo-controlled, randomized, Phase 1b crossover trial comparing two doses of ulotaront with placebo in the treatment of narcolepsy-cataplexy (2023) (0)
Pharmacologic therapy for sleep-related breathing disorders (2008) (0)
0336 Sleep Time and Risk Taking Behaviour in Night Shift-Workers (2022) (0)
Dosedeterminants ofrebound insomnia (1986) (0)
0374 Effects of Suvorexant on Pain Sensitivity in Fibromyalgia (2019) (0)
ESOMEPRAZOLE REDUCES THE COSTS OF REDUCED WORK PRODUCTIVITY DUE TO GERD-RELATED SLEEP DISTURBANCES: 720 (2004) (0)
490 Efficacy of FT218 on Polysomnographic Measures of Sleep Continuity in Patients With Narcolepsy: Results From the REST-ON Trial (2021) (0)
Laboratory Methodology Course (2005) (0)
0006 The Pharmacokinetics and Pharmacodynamics of SM-1 (2018) (0)
0440 Subjective Sleep Outcomes with Lemborexant Among Subjects with Insomnia and Clinically Meaningful Decreases on the Insomnia Severity Index (2022) (0)
Ford Insomnia Response to Stress Test--European Portuguese Version (2018) (0)
The Risk of Verified Motor Vehicle Crashes in a Population-Based Study of Individuals with Impaired Physiological Alertness as Measured by the Multiple Sleep Latency Test (MSLT) (2010) (0)
Brief Insomnia Questionnaire (2014) (0)
0462 Baseline Sleep Disturbance and Inability to Discontinue Chronic Hypnotic Use (2022) (0)
Sleep and psychiatric disorders. Editorial. (1994) (0)
THE NATURE OF STABLE INSOMNIA PHENOTYPES The Nature of Stable Insomnia Phenotypes (2014) (0)
0465 Association Between Physical or Sexual Abuse and Sleep Reactivity in Patients with Insomnia (2020) (0)
Time of drinking, sleep restriction, and the sedative effects of ethanol (1994) (0)
0335 Polysomnography in Insomnia Disorder (2019) (0)
Shift Work: A Perspective on Shift Work Disorder-Is Prevention the Answer? (2019) (0)
CHAPTER 14 – THE PHYSIOLOGY OF SLEEP (2007) (0)
Drug-Related Sleep Stage Changes: Functional and Clinical Relevance (2010) (0)
0497 Rebound Insomnia During Discontinuation of Chronic Hypnotic Use (2020) (0)
Idiopathic hypersomnia symptom diary (IHSD): development of a new patient reported outcome (PRO) measure (2019) (0)
Insomnia Pharmacotherapy (2012) (0)
Polysomnographic assessment of hypnotic efficacy in the elderly (1993) (0)
Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 data (2017) (0)
Cytokines and sleep: effects on daytime sleepiness (2017) (0)
45 S-49 S Benzodiazepines and memory (2006) (0)
A CURE FOR SANTA'S SLEEP APNOEA (1986) (0)
Irritable Bowel Syndrome, Immune Fitness, and Insomnia: Results from an Online Survey Among People Reporting Sleep Complaints (2019) (0)
Efficacy and safety of zolpidem tartrate sublingual tablet for as-needed treatment of MOTN insomnia (2011) (0)
ArmodAfinil for ExcEssivE slEEpinEss with JEt lAg disordEr (2010) (0)
The consequences of nocturnal REM deprivation on the level of daytime sleepiness (1994) (0)
Unique REM Rebound Following Sleep Restriction in Fibromyalgia Patients Is Not Related to a Prior History of Depression (2007) (0)
Prospects for insomnia treatment (2006) (0)
SLEEPLABORATORY AND PERFORMANCE EVALUATIONOF MIDAZOLAM ININSOMNIACS (1983) (0)
Objective and subjective benefits of pregabalin on measures of sleep efficiency in patients with fibromyalgia and sleep maintenance disturbance (2011) (0)
University of Groningen The Association of Insomnia , Perceived Immune Functioning , and Irritable Bowel Syndrome (2018) (0)
SLEEP in 1998: Broadening our scope, enriching our vision (1998) (0)
Lapses of attention as outcome measure of the on-the-road driving test (2013) (0)
Pain Disorders (2020) (0)
EFFECTSOF ACUTE ADMINISTRATIONOF BROTIZOLAM INSUBJECTSWITH DISTURBEDSLEEP (1983) (0)
Markers for Hypnotic Abuse Liability: Cortisol in Insomnia? (2017) (0)
Japanese Version of the Ford Insomnia Response to Stress Test (2014) (0)
Effect of sodium oxybate on sleep stage shifts and sleep quality in patients with narcolepsy (2013) (0)
0401 Efficacy of Once-Nightly Sodium Oxybate (ON-SXB; FT218) By Narcolepsy Type: Post-hoc Analyses From the REST-ON Trial (2022) (0)
The Reliability of the Diagnostic with Narcolepsy Features in Patients (1996) (0)
T-D-001 ABSENCE OF TOLERANCE, DEPENDENCE POTENTIAL, AND REBOUND DURING PRN TREATMENT OF MIDDLE-OF-THE-NIGHT AWAKENINGWITH ZOLPIDEM TARTRATE SUBLINGUAL TABLET 3.5MG (2011) (0)
LAPSES OF ATTENTION DURING DRIVING IN THE ALCOHOL HANGOVER STATE (2013) (0)
Twenty years of evolution: Looking back as SLEEP enters a new era (1998) (0)
Clinical Practice Assessment of Primary Care Practices in the Detection and Management of Shift Work Disorder: Laying the Groundwork for Delivering CME and Measuring Educational Outcomes (2013) (0)
DOSE-RELATED EFFECTS OF PHENOBARBITONE ON HUMAN SLEEP-WAKING PATI7ERNS (2006) (0)
Brief communication Sleepiness/alertness among healthy evening and morning type individuals q (2001) (0)
0372 Arousability of Insomnia Patients is Not Impacted by the Orexin Antagonist Suvorexant (10 mg and 20 mg) (2019) (0)
A Nationally Representative Survey Assessing Restorative Sleep in US Adults (2022) (0)
Typologies of individuals vulnerable to insomnia: a two-step cluster analysis (2020) (0)
Effectiveness of Recruiting Type 1 Narcolepsy Patients via Internet Based Pre-Selection System (2017) (0)
Obituary for Gerald W. Vogel, MD. (2012) (0)
Alcohol Hangover, Sleep Quality, and Daytime Sleepiness (2017) (0)
The effects of middle-of-the-night administration of hypnotic drugs on next-morning on-road driving performance (2015) (0)
0353 PRELIMINARY DATA FOR THE SLEEP TO PREVENT EVOLVING AFFECTIVE DISORDERS (SPREAD) TRIAL (2017) (0)
In reply [6] (2006) (0)
0378 Are People with Severe Insomnia Able to Discontinue Hypnotics after Chronic Use? (2019) (0)
T-D-032 TREATMENT OF MIDDLE-OF-THE-NIGHT INSOMNIA: CURRENT MEDICAL PRACTICE (2011) (0)
PREVALENCE AND PSG OF INSOMNIA COMORBID WITH MEDICAL CONDITIONS (2011) (0)
More on insomnia disorders in older patients (2015) (0)
P6.048 Patient functional status/quality of life, safety,and tolerability with long-term modafinil in chronic shiftwork sleep disorder (2004) (0)
0403 Efficacy of Once-nightly Sodium Oxybate (ON-SXB; FT218) for Excessive Daytime Sleepiness and Cataplexy: Post-hoc Number Needed to Treat and Effect Size Analyses From REST-ON (2022) (0)
Sleep Onset-REM and NREM Sleep The Frequency of Multiple Sleep Onset REM Periods Among Subjects With No Excessive Daytime Sleepiness (2001) (0)
0416 Inability to Discontinue Chronic Hypnotic Use (2018) (0)
PND23 CONCORDANCE OF SELF-REPORT MEASURES OF DSM-IV-TR, ICD-IO, AND RDC INSOMNIA WITH STANDARDIZED CLINICAL ASSESSMENTS IN THE AMERICA INSOMNIA SURVEY (AIS) (2010) (0)
EXCESSIVE DAYTIME SLEEPINESS ( EDS ) IN PARKINSON ’ S DISEASE ( PD ) PATIENTS WITH UNINTENDED SLEEP EPISODE ( USE ) WHEN TREATED WITH DOPAMINERGIC AGENTS ( DA ) (2004) (0)
Clinical Development of Hypnotics (1996) (0)
0337 Insomniacs in Late Pregnancy are Clinically Depressed: Exploring the Role of Nocturnal Rumination (2019) (0)
New perspectives on the pharmacologie management of insomnia (2001) (0)
0007 Daytime Sleep in Night Shift Workers: Quantifying the Role of Circadian Misalignment (2020) (0)
Characteristics of subjects excluded form an idiopathic hypersomnia randomized clinical trial (ARISE2) (2019) (0)
ALCOHOL HANGOVER EFFECTS ON STANDARD DEVIATION OF LATERAL POSITION AND LAPSES OF ATTENTION DURING SIMULATED HIGHWAY DRIVING (2013) (0)
Global Sleep Assessment Questionnaire (2012) (0)
NSS_A_226291 301..315 (2019) (0)
20 The Effect of Medical Treatment of Gastroesophageal Reflux on the Severity of Obstructive Sleep Apnea (1995) (0)
Dual orexin receptor antagonist, almorexant, in elderly patients with primary insomnia: a randomized, controlled study. (2016) (0)
Current and Emerging Pharmacotherapies for the Treatment of Insomnia: Efficacy and Safety (2009) (0)
0339 Effectiveness of Recruiting Type 1 Narcolepsy Patients via Internet Based Pre-selection System (2018) (0)
P.1.i.001 Sublingual 3.5mg zolpidem for middle-of-the-night insomnia: no tolerance, rebound or increase in use over 4 weeks (2010) (0)
Sleep Disorders in Addiction: An Overview (2020) (0)
Recognizing and Treating Excessive Daytime Sleepiness in Patients With Narcolepsy. (2020) (0)
Online medical education improves knowledge of physiologic mechanisms of sleep among neurologists and primary care clinicians (2019) (0)
ARMODAFINIL SUSTAINS WAKEFULNESS THROUGHOUT THE DAY IN PATIENTS WITH EXCESSIVE SLEEPINESS WHO ARE OTHERWISE WELL TREATED FOR OBSTRUCTIVE SLEEP APNEA (2008) (0)
0463 Sleep Assessed by Actigraphy during Discontinuation of Chronic Hypnotic Use (2022) (0)
Are reports of mental fog from patients with idiopathic hypersomnia mediated by objective measures of daytime sleepiness? (2019) (0)
Predicting psychopharmacological drug effects on actual driving performance (SDLP) from psychometric tests measuring driving-related skills (2011) (0)
The pharmacokinetics of once-nightly controlled- release Sodium Oxybate (FT218): overview of results from four phase 1 studies (2019) (0)
The impact of lemborexant treatment on insomnia disease severity: results from a pooled analysis of two phase 3 studies (2019) (0)
Drivers can poorly predict their own driving impairment: a comparison between measurements of subjective and objective driving quality (2011) (0)
0005 Efficacy of SM-1 in a Transient Insomnia Model (2018) (0)
The Assessment of Treatment Efficacy (2005) (0)
The art of good sleep, Paris, France, September 2004 (2005) (0)
0496 Self-Reported Sleep During Discontinuation of Chronic Hypnotic Use (2018) (0)
Polysomnography in insomnia disorder (2019) (0)
0374 Markers for Hypnotic Abuse Liability: Cortisol in Insomnia? (2018) (0)
Efficacy of the triple-combination SM-1 in a 5-h phase advance transient insomnia model (2021) (0)
Improvement of obstructive sleep apnea after radiation therapy of vocal cord carcinoma. (2007) (0)
Marijuana normalizes sleep efficiency in marijuana-dependent volunteers (2014) (0)
Incorporating patient input into clinical trials (2017) (0)
Risk-Taking Behavior: Effects of Ethanol, Caffeine, and Basal Sleepiness SLEEP, SLEEP RESTRICTION AND PERFORMANCE (2004) (0)
Insomnia: Etiology, Clinical Manifestations, and Morbidity (2012) (0)
P097 Incidence of abnormal dreams and nightmares with lemborexant in adults with insomnia: results from two Phase 3 studies (2021) (0)
THE NATURE AND PREVALENCE OF MIDDLE-OF-THE-NIGHT USE OF PRESCRIPTION HYPNOTICS (2011) (0)
Validation of Somno-Art Software, a novel approach of sleep staging, compared with polysomnography in disturbed sleep profiles (2021) (0)
P.1.j.010 Lapses during on road driving: determining a cut-off value for clinically relevant driving impairment (2015) (0)
Tachypnea Seen During Positive Airway Pressure Titration Studies: A Case Series of Four Patients. (2018) (0)
0331 ACTIGRAPHY IN INSOMNIA WITH AND WITHOUT EVENT-MARKING (2017) (0)
Study of the pharmacodynamic interaction between zaleplon and triazolam and ethanol on psychomotor performance in healthy subjects (2002) (0)
Self-administration of hypnotics: Dose escalation (1993) (0)
0330 AT-HOME ACTIGRAPHY VS IN-LABORATORY PSG IN INSOMNIA (2017) (0)
SLEEP AFTER TRANSMERIDIAN FLIGHTS (1987) (0)
Response to: Once-nightly sodium oxybate (FT218) in the treatment of narcolepsy: a letter to the editor commenting on the recent publication by C. Kushida et al (2022) (0)
A Generalized Estimating Equation Approach to Analysis of Maintenance of Wakefulness Testing in a Study of Lisdexamfetamine Dimesylate, Armodafinil, and Placebo in Sleep-Deprived Adults (2014) (0)
Pain epidemiology: Exploratory evaluation of objective sleep disturbance using polysomnography in neuropathic pain (2004) (0)
Sleep disorders and alcohol (multiple letters) (2002) (0)
Sleep: Past, present and future (2002) (0)
488 REST-ON: Efficacy of FT218 for Daytime Sleepiness, Sleep Quality, Hallucinations, and Sleep Paralysis in Patients With Narcolepsy (2021) (0)
The Impact of Having a 15-min Break With and Without Consuming an Energy Drink on Prolonged Simulated Highway Driving (2015) (0)
The interaction of daytime sleepiness and sedative properties of drugs. (1987) (0)
A two-night polysomnography preliminary study in pregnant women with insomnia: Suicidal ideation and nocturnal cognitive arousal prospectively predict objective nocturnal wakefulness (2023) (0)
Insomnia and Driving Ability on Perrier et al. Impaired driving performance associated with effect of time duration in patients with primary insomnia. SLEEP (2014) (0)
Comprar Insomnia, An Issue of Sleep Medicine Clinics | Thomas Roth | 9781416039211 | Saunders (2007) (0)
Sex Differences in Middle-of-the-Night Efficacy of Zolpidem Tartrate Sublingual Tablets in a 4-Week Insomnia Outpatient Trial (P05.013) (2013) (0)
0402 Efficacy of FT218, a Once-Nightly Sodium Oxybate Formulation, in Patients With Narcolepsy: Post-hoc Sensitivity Analyses From the REST-ON Trial (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Thomas Roth?

Thomas Roth is affiliated with the following schools:

Thomas Roth's Academic­Influence.com Rankings

Thomas Roth's Degrees

Similar Degrees You Can Earn

Why Is Thomas Roth Influential?

Thomas Roth's Published Works

Published Works

What Schools Are Affiliated With Thomas Roth?

Thomas Roth's AcademicInfluence.com Rankings